Document is current
Any future updates will be listed below
-
Authors
Boudin, Laurys
de Nonneville, A
Finetti, Pascal
Mescam, Léna
Le Cesne, A
Italiano, Antoine
Blay, Jean-Yves
Birnbaum, Daniel
Mamessier, Emilie
Bertucci, François http://orcid.org/0000-0002-0157-0959
-
Funding
Funding for this research was provided by:
Ligue Contre le Cancer (EL2022)
Prix Ruban Rose (2020)
LYRINCAN (INCA-DGOS-INSERM 12563)
NetSarc (INCA)
InterSARC (INCA)
LabEx DEvweCAN (ANR-10-LABX-0061)
EURACAN (EC 739521)
- License Information
-
More Information
Article History
Received: 6 August 2022
Accepted: 29 September 2022
First Online: 11 October 2022
Declarations
:
: Our <i>in silico</i> study is based upon public data from published studies in which the informed patient's consent to participate and the ethics and institutional review board were already obtained by authors. The study was approved by our institutional review board.
: Not applicable.
: ALC received consulting fees from Pharmamar, Bayer, and Deciphera. The other authors have declared no conflict of interest.
